Potential antiviral role of p53 in HCV-infected patients

被引：0
|
作者：
Hamdi, N. [1 ]
El-Serafy, M. [2 ]
Esmat, G. [2 ]
Alaakel, W. [2 ]
Abdelaziz, A. I. [1 ]
机构：
[1] German Univ Cairo, Cairo, Egypt
[2] Cairo Univ, Cairo, Egypt
来源：
FEBS JOURNAL | 2009年 / 276卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：312 / 313
页数：2
相关论文
共 50 条
  • [41] THE EXPRESSION OF TBK1S IN HCV-INFECTED PATIENTS
    Han, M.
    Li, W.
    Luo, X.
    Ning, Q.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S126 - S126
  • [42] Significance of repeatedly normal aminotransferase activities in HCV-infected patients
    Zylberberg, H
    Pol, S
    Thiers, V
    Chaix, ML
    Lagorce, D
    Bréchot, C
    Nalpas, B
    Berthelot, P
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 1999, 29 (01) : 71 - 75
  • [43] Health-related quality of life in HCV-infected patients
    Groessl E.J.
    Weingart K.R.
    Kaplan R.M.
    Ho S.B.
    Current Hepatitis Reports, 2007, 6 (4) : 169 - 175
  • [44] ROLE OF INTERLEUKIN 28B POLYMORPHISMS IN THE OUTCOME OF LIVER TRANSPLANTATED HCV-INFECTED PATIENTS
    Bertinetto, Francesca E.
    Romagnoli, Renato
    Hernandez, Pablo J. Bogantes
    Salizzoni, Mauro
    Magistroni, Paola
    Dametto, Ennia
    Garino, Elena
    Fasano, Maria E.
    Amoroso, Antonio
    TISSUE ANTIGENS, 2012, 79 (06): : 481 - 481
  • [45] Acetylation is indispensable for p53 antiviral activity
    Munoz-Fontela, Cesar
    Gonzalez, Dolores
    Marcos-Villar, Laura
    Campagna, Michela
    Gallego, Pedro
    Gonzalez-Santamaria, Jose
    Herranz, Daniel
    Gu, Wei
    Serrano, Manuel
    Aaronson, Stuart A.
    Rivas, Carmen
    CELL CYCLE, 2011, 10 (21) : 3701 - 3705
  • [46] Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study
    Carrion, Jose A.
    Martinez-Bauer, Eva
    Crespo, Gonzalo
    Ramirez, Santseharay
    Perez-del-Pulgar, Sofia
    Carlos Garcia-Valdecasas, Juan
    Navasa, Miquel
    Forns, Xavier
    JOURNAL OF HEPATOLOGY, 2009, 50 (04) : 719 - 728
  • [47] Renal function changes in HCV-infected patients with chronic kidney disease during and after treatment with direct antiviral agents
    Dell'Acqua, Raffaele
    De Vita, Giuseppina
    Procopio, Andrea
    Milella, Michele
    Saracino, Annalisa
    Angarano, Gioacchino
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (10) : 1166 - 1169
  • [48] Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon
    Mascia, Claudia
    Vita, Serena
    Zuccal, Paola
    Marocco, Raffaella
    Tieghi, Tiziana
    Savinelli, Stefano
    Rossi, Raffaella
    Iannetta, Marco
    Pozzetto, Irene
    Furlan, Caterina
    Mengoni, Fabio
    Mastroianni, Claudio Maria
    Vullo, Vincenzo
    Lichtner, Miriam
    PLOS ONE, 2017, 12 (06):
  • [49] Real-world experience with direct-acting antiviral therapy in HCV-infected patients with cirrhosis and esophageal varices
    Brzdek, Michal
    Zarebska-Michaluk, Dorota
    Kukla, Michal
    Janocha-Litwin, Justyna
    Dybowska, Dorota
    Janczewska, Ewa
    Lorenc, Beata
    Berak, Hanna
    Mazur, Wlodzimierz
    Tudrujek-Zdunek, Magdalena
    Klapaczynski, Jakub
    Piekarska, Anna
    Sitko, Marek
    Laurans, Lukasz
    Parfieniuk-Kowerda, Anna
    Flisiak, Robert
    PHARMACOLOGICAL REPORTS, 2024, 76 (05) : 1114 - 1129
  • [50] SUCCESSFUL ANTIVIRAL TREATMENT DECREASES THE PROPORTION OF HCV-INFECTED LIVER TRANSPLANT CANDIDATES IN THE WAITING LIST
    Malinovskaya, Yulia
    Kokina, Ksenia
    Moysyuk, Yan
    TRANSPLANT INTERNATIONAL, 2019, 32 : 195 - 196
12345